Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00432289 · ClinicalTrials.gov registry record · Phase 1
Acupuncture for Treatment of Acute Spinal Cord Injury: an Exploratory/Developmental Study
A Phase 1 study, sponsored by Craig Hospital.
- Completed
- Registry status
- Phase 1
- Development phase
- 30
- Enrollment target
NCT00432289: Completed Phase 1 study, sponsored by Craig Hospital.
NCT00432289 is a Phase 1 study that has completed, run by Craig Hospital. The registered enrollment target is 30 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (50% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00432289, a Phase 1 study, has completed, sponsored by Craig Hospital.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 30 participants
- Enrollment target
Study Summary
Specific Aim: to implement and evaluate a research protocol for demonstrating the efficacy of Acupuncture Therapy to improve neurological recovery after incomplete SCI compared to a control protocol. Hypothesis: acupuncture treatment results in greater neurological recovery than a control treatment after an incomplete SCI. Before conducting a larger, more definitive study, this exploratory and developmental work is focused on assessing whether blinding is possible, reproducibility of the outcome measure, determine enrollment rates and effect sizes and identify clinical resources needed to conduct a larger study.
Interventions
- PROCEDURE Acupuncture
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2006-11 |
| Est. Completion | 2009-06 |
| Phase | Phase 1 |
What the finished NCT00432289 record still lists
NCT00432289 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (50% lower).
The record links to 0 conditions, and to 1 intervention - of which Acupuncture is the first listed.
NCT00432289 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00432289 about?
NCT00432289 is a clinical study titled "Acupuncture for Treatment of Acute Spinal Cord Injury: an Exploratory/Developmental Study". Specific Aim: to implement and evaluate a research protocol for demonstrating the efficacy of Acupuncture Therapy to improve neurological recovery after incomplete SCI compared to a control protocol. Hypothesis: acupuncture treatment results in greater neurological recovery than a control treatment...
What is the current status of trial NCT00432289?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2006-11. Estimated completion is 2009-06.
What interventions are being tested in trial NCT00432289?
The interventions under investigation include: Acupuncture (PROCEDURE).
Who is sponsoring clinical trial NCT00432289?
This trial is sponsored by Craig Hospital, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00432289's enrollment target sits among peer trials
30 1332nd of 2000 higher than 561 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia